Pfizer and BioNTech are asking the FDA to approve the use of its COVID vaccine for kids 12 to 15.
Last week, Pfizer said late-stage clinical trials showed the vaccine was safe and 100% effective for children in that age bracket.
But those findings haven't been peer reviewed yet.
Pfizer is also studying how well the shot works in children 6 months to 11 years old.